BNP PARIBAS FINANCIAL MARKETS - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 121 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$5,0000.0%10.0%0.00%
Q2 2021$5,0000.0%10.0%0.00%
Q1 2021$5,000
+25.0%
10.0%0.00%
Q4 2020$4,0000.0%10.0%0.00%
Q3 2020$4,000
-100.0%
1
-100.0%
0.00%
Q2 2020$49,892,000
+140.4%
19,489
+171.4%
0.00%
Q1 2020$20,756,000
-3.0%
7,182
+27.2%
0.00%
Q4 2019$21,406,000
+15.9%
5,648
+56.4%
0.00%
Q3 2019$18,470,000
+18.6%
3,611
+43.8%
0.00%
Q2 2019$15,568,000
-53.0%
2,511
-46.1%
0.00%
Q1 2019$33,111,000
+132.0%
4,657
+553.2%
0.00%
Q3 2018$14,274,000
-22.5%
7130.0%0.00%
Q2 2018$18,417,000
-78.8%
713
-80.4%
0.00%
Q1 2018$86,733,000
-19.4%
3,629
+14.2%
0.00%
Q4 2017$107,669,000
+204.0%
3,177
+89.9%
0.00%
Q3 2017$35,417,000
+13.3%
1,673
-6.4%
0.00%
Q2 2017$31,255,000
+5656.0%
1,787
+5664.5%
0.00%
Q1 2017$543,000
-88.5%
31
-88.9%
0.00%
Q4 2016$4,732,000
-75.4%
280
-76.1%
0.00%
Q3 2016$19,249,000
+94.7%
1,173
+79.6%
0.00%
Q2 2016$9,886,000
-82.9%
653
-68.1%
0.00%
Q4 2015$57,942,000
+67.9%
2,046
-0.7%
0.00%
Q3 2015$34,501,000
+52.1%
2,061
+138.3%
0.00%
Q2 2015$22,680,000
+1752.9%
865
+1135.7%
0.00%
Q1 2015$1,224,000
-28.5%
70
-23.9%
0.00%
Q3 2014$1,713,000920.00%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,423,578$8,826,0006.08%
Healthcare Value Capital, LLC 200,000$1,240,0002.33%
ARMISTICE CAPITAL, LLC 2,700,000$16,740,0001.06%
DELTEC ASSET MANAGEMENT LLC 550,836$3,415,0000.75%
Broadfin Capital, LLC 441,088$2,735,0000.60%
Kerrisdale Advisers, LLC 229,347$1,422,0000.51%
Worth Venture Partners, LLC 87,908$545,0000.30%
Mosaic Family Wealth, LLC 91,314$566,0000.24%
EMERALD ADVISERS, LLC 700,176$4,341,0000.17%
EMERALD MUTUAL FUND ADVISERS TRUST 616,664$3,823,0000.15%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders